Open AccessComparable prognosis in different neonatal histidine-tryptophan-ketoglutarate dosage management
Author(s) -
Liting Bai,
Yuanyuan Tong,
Jinping Liu,
Zheng-Yi Feng,
Zhao Ju,
Simin Guo,
Yu Jin,
Pei-Yao Zhang,
Yixuan Li
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001643
Subject(s) - medicine , dose , cardiopulmonary bypass , anesthesia , perfusion , regimen , surgery
Histidine-tryptophan-ketoglutarate (HTK) is a solution commonly used for organ transplantation. However, there is no certified fixed regimen for on-pump heart surgery in neonates. We aimed to retrospectively evaluate the outcomes related to different HTK dosages and to analyze the safety of high-dosage perfusion.